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Thalamocortical (TC) neurons, including those of the dorsal lat-
eral geniculate nucleus (dLGN), one of the visual sensory thala-
mic nuclei, exhibit two forms of GABAA receptor-mediated
inhibition: phasic or classical inhibitory postsynaptic currents
(IPSCs) generated by the activation of synaptic GABAA receptors
(sGABAAR) and tonic inhibition generated by extra- or peri-
synaptic GABAA receptors (eGABAAR) [1,2]. The source of GABA
mediating tonic inhibition mostly arises from spillover out of the
synaptic cleft, because tonic inhibition is blocked by TTX and
removal of extracellular Ca2+ in adult murine dLGN TC neurons
[3]. Therefore, modulation of vesicular GABA release may not
only affect phasic but also tonic inhibition [1,4]. Previous work in
the cat and rat dLGN has shown that several neurotransmitters,
including acetylcholine, serotonin (5-HT), dopamine, and nore-
pinephrine can modulate vesicular GABA release from inhibitory
interneurons, resulting in changes in phasic inhibition (IPSC fre-
quency), primarily through presynaptic modulation of GABA
release from dendro-dendritic synapses [5]. However, except for
dopamine in the somatosensory thalamus, the effect of these neu-
rotransmitters on tonic GABAA inhibition in TC neurons has not
been examined. Here, we investigated whether 5-HT and its
5-HT1A, 5-HT2A and 5-HT2C receptors exert a control over tonic
and phasic GABAA currents in dLGN TC neurons. We used whole
cell patch clamp recordings in coronal slices (300 mm) containing
the dLGN from postnatal day 20–25 Wistar rats. Data analysis and
experimental procedures were similar to those previously
described [1,6] and in accordance with the Animals (Scientific
Procedures) Act 1986 (UK). Focal application of gabazine (GBZ,
100 mM) was used to reveal the presence of tonic GABAA current
(Figure 1). All serotonergic drugs were dissolved in the recording
solution, and their concentrations, co-administration, and effects
on phasic and tonic GABAA current are shown in Table 1 and Fig-
ure 1. We found that 5-HT enhances phasic GABAA inhibition
(i.e., spontaneous IPSCs), but has no action on tonic inhibition.
These effects are identical to those observed following 5-HT1A/7R
activation with 8-OH-DPAT. On the other hand, a-M-5-HT and
mCPP enhances and reduces, respectively, both phasic and tonic
GABAA inhibition. These effects are dependent on 5-HT2AR and
5-HT2CR activation, respectively, as they are blocked by co-perfu-
sion with selective antagonists, ketanserin, and SB242084. Thus,
the lack of 5-HT modulation of tonic inhibition might be
explained by the counterbalance of co-activation of 5-HT2ARs and
5-HT2CRs by the endogenous ligand (Figure 1 and Table 1).
Our findings are in agreement with recent evidence in visual
cortex showing that 5-HT enhances phasic inhibition by activating
5-HT2ARs (via calcium/calmodulin-dependent protein kinase II,
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Figure 1 Serotoninergic modulation of phasic and tonic GABAA currents in TC neurons of the dLGN. The tonic GABAA current was measured as the
outward change in baseline current following focal (via a pipette) application of the GABAA antagonist gabazine (100 lM, GBZ, gray bar) (holding potential:
70 mV), as previously described (1). Baseline current was measured as the averaged 20 seconds current before GBZ application, while the shift in
baseline current was measured as the averaged 20 seconds current after GBZ application. Focal application of GBZ (100 lM) reveals different magnitude
of tonic GABAA current. Each 5-HTR ligand was applied in the recording solution, either alone or in combination, and only one TC neuron was recorded in
each slice. sIPSCs recorded in the different experimental conditions were collected before GBZ application and analyzed as previously described [6]. (A)
Representative current traces from different TC neurons obtained under control condition, and in continuing presence of 5-HT (50 lM, black box),
8-OH-DPAT (100 lM, blue box), a-M-5-HT (100 lM, red box), 100 lM a-M-5-HT and 10 lM ketanserin (gray box), 100 lM a-M-5-HT and 10 lM SB242084
(purple box), 50 lM mCPP (green box), and 50 lM mCPP and 10 lM SB242084 (yellow box). For each current recording (top traces), a representative
pre-GBZ period (2 seconds long, bottom traces) shows IPSCs elicited during different 5-HT drug treatments. Summary of the effects of the different 5-HT
ligands and their combinations on tonic current (B) and sIPSC frequency (C). *P < 0.05, **P < 0.01, ***P < 0.002 versus control group. ##P < 0.01 a-M-5-
HT + SB242084 versus a-M-5-HT. P < 0.01 mCPP and SB242084 versus mCPP. One-way ANOVA, Dunnett’s multiple comparison tests. 5-HT, serotonin;
8-OH-DPAT, ()-2-Dipropylamino-8-hydroxy-1,2,3,4-tetrahydronaphthalene; a-M-5-HT mCPP, meta-chlorophenylpiperazine. sIPCS, spontaneous inhibitory
postsynaptic current. SB 242084, 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxamide hydrochloride.
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CaMKII) [7]. However, whereas in visual cortex 5-HT decreases
tonic inhibition via a 5-HT1AR-dependent suppression of protein
kinase A (PKA) activity) [7], we could not detect any effect on the
tonic current by 5-HT or 5-HT1A/7R activation in the dLGN.
Moreover, our study is in agreement with previous in vivo stud-
ies in which stimulation of the dorsal raphe nucleus decreased TC
neuron firing in the dLGN [8], suggesting 5-HT had an inhibitory
action. In contrast, however, in vitro intracellular recordings of fer-
ret TC cells found that 5-HT is predominantly hyperpolarizing in
all thalamic nuclei tested except for the dLGN, medial geniculate
and in a subset of pulvinar neurons, in which depolarizing
responses were observed [9]. More recently, it has been shown
that in rats 5-HT excites all TC neurons in first-order thalamic
nuclei and most (85%) TC neurons in higher order nuclei, while
it hyperpolarizes the remaining cells [10]. Specifically in the rat
dLGN, 5-HT2CR activation with a-M-5-HT and the highly selective
ligand CP-809,101 produced depolarization of TC neurons shifting
their firing from bursts to tonic [11]. This would suggest that sero-
tonin has a complex modulatory effect on thalamic nuclei which
appear to be nucleus-, 5-HTR subtype-, and 5-HTR synaptic local-
ization-dependent. 5-HT1A/7 are present in the thalamus [12], and
whereas a strong 5-HT2CR immunoreactivity has been detected,
although not somatically, in dLGN TC neurons [13], 5-HT2AR
immunostaining did not reach detectable levels [11]. Interest-
ingly, both 5-HT2AR and 5-HT2CR mRNA are expressed in the
dLGN GABAergic interneurons of young rats [14]. Therefore, it is
likely that the increase in sIPSC frequency that we observed in
our study may result from postsynaptic 5-HT2Rs on dendritic F2
terminals of dLGN interneurons, as previously shown [14].
Nevertheless, 5-HT1A/7R and 5-HT2A/2CRs might also be located
postsynaptically on TC neurons, and their activation may lead to
phosphorylation of different subunits of sGABAARs and eGA-
BAARs acting to differentially modulate their function. The bind-
ing of 5-HT to 5-HT1A/7R and 5-HT2A/2CRs might activate multiple
signal transduction cascades, which ultimately activate different
protein kinases, such as PKA or protein kinase C (PKC) and differ-
ently regulate sGABAARs and eGABAARs, as indicated by our
results. On the other hand, the potential contribution of 5-HTRs
on retinal and cortical terminals can be ruled out as glutamatergic
function was blocked in our preparations through the addition of
kynurenic acid to the recording solution.
Overall, this study is the first to show a modulation of tonic
GABAA current by 5-HTRs in the thalamus and also to highlight
that phasic and tonic inhibition in the dLGN are modulated by
5-HT through different receptor subtypes, leading to a finely
tuned balance of sensory information processing in the dLGN. By
showing a differential modulation of phasic versus tonic GABAA
inhibition, our results demonstrate a novel mechanism by which
the ascending serotonergic afferents can control the thalamic gate
to the visual cortex in a behavioral state-dependent manner.
Moreover, because of the putative role for thalamic tonic GABAA
inhibition in sleep regulation and pathological oscillations, such
as those present in absence epilepsy, the opposing effects of
5-HT2ARs and 5-HT2CRs activation may provide suitable targets
for pharmacological intervention in sleep and other CNS
disorders.
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